Continuous-Flow Kinetic Resolution of (±)-cis-1-Amino-2-indanol by Lipase-Catalyzed N-Acetylation

Yoon-Jung Kim; Yong-Sung Choi; Sai Yang; Woo Ram Yang; Jin-Hyun Jeong

doi:10.1055/s-0034-1380427

Synlett, Inhaltsverzeichnis

Synlett 2015; 26(14): 1981-1984
DOI: 10.1055/s-0034-1380427

letter

Continuous-Flow Kinetic Resolution of (±)-cis-1-Amino-2-indanol by Lipase-Catalyzed N-Acetylation

Yoon-Jung Kim

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 406-840, Republic of Korea eMail: organicjeong@yonsei.ac.kr

,

Yong-Sung Choi

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 406-840, Republic of Korea eMail: organicjeong@yonsei.ac.kr

,

Sai Yang

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 406-840, Republic of Korea eMail: organicjeong@yonsei.ac.kr

,

Woo Ram Yang

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 406-840, Republic of Korea eMail: organicjeong@yonsei.ac.kr

,

Jin-Hyun Jeong*

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 406-840, Republic of Korea eMail: organicjeong@yonsei.ac.kr

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

Selective N-acetylation of (1S,2R)-1-amino-2-indanol by immobilized lipase B from Candida antarctica showed high enantiomeric excess when ethyl acetate was used as the acyl donor in a THF solution. Combining this process with continuous-flow system, we could obtain enantiomerically pure N-acetyl-aminoindanol at a flow rate of 0.1 mL/min (residence time of 64 min). It has been demonstrated to be more efficient compared to the flask mode.

Key words

(±)-cis-1-amino-2-indanol - Novozyme 435^® - continuous-flow system - kinetic resolution - selective N-acetylation

Volltext

Referenzen

References and Notes
1 Kagan H, Fiaud J. Top. Stereochem. 1988; 18: 249

2a Ferreira EM, Stoltz BM. J. Am. Chem. Soc. 2001; 123: 7725
2b Ruble JC, Latham HA, Fu GC. J. Am. Chem. Soc. 1997; 119: 1492
2c Miller SJ, Copeland GT, Papaioannou N, Horstmann TE, Ruel EM. J. Am. Chem. Soc. 1998; 120: 1629

3a Nestl BM, Nebel BA, Hauer B. Curr. Opin. Chem. Biol. 2011; 15: 187
3b Jaeger K.-E, Eggert T. Curr. Opin. Chem. Biol. 2002; 13: 390

4 Hessel V, Hardt S, Löwe H, Müller A, Kolb G. Chemical Micro Process Engineering . Vol. 1 and 2. Wiley-VCH; Weinheim: 2005

5a Itabaiana IJr, Gonçalves KM, Zoumpanioti M, Leal IC, de Miranda LS, Xenakis A, de Souza RO. Org. Process Res. Dev. 2014; 18: 1372
5b Junior II, Flores MC, Sutili FK, Leite SG, de Miranda LS, Leal IC, de Souza RO. Org. Process Res. Dev. 2011; 16: 1098
5c Porcar R, Sans V, Ríos-Lombardía N, Gotor-Fernández V, Gotor V, Burguete MI, García-Verdugo E, Luis SV. ACS Catal. 2012; 2: 1976
5d Sahin S, Mäki-Arvela P, Kangas M, Eränen K, Wärnnå J, Salmi T, Murzin DY. Kinet. Catal. 2012; 53: 673
5e Strompen S, Weiß M, Gröger H, Hilterhaus L, Liese A. Adv. Synth. Catal. 2013; 355: 2391
5f Wiles C, Hammond MJ, Watts P. Beilstein J. Org. Chem. 2009; 5: 27
5g Žnidaršič-Plazl P, Plazl I. Process Biochem. 2009; 44: 1115

6 Tomin A, Hornyánszky G, Kupai K, Dorkó Z, Ürge L, Darvas F, Poppe L. Process Biochem. (Oxford, U.K.) 2010; 45: 859
7 de Miranda AS, Miranda LS, de Souza RO. Org. Biomol. Chem. 2013; 11: 3332

8a Dorsey BD, Levin RB, McDaniel SL, Vacca JP, Guare JP, Darke PL, Zugay JA, Emini EA, Schleif WA. J. Med. Chem. 1994; 37: 3443
8b Vieth M, Cummins DJ. J. Med. Chem. 2000; 43: 3020
8c Kheffache D, Guemmour H, Dekhira A, Benaboura A, Ouamerali O. J. Mol. Model. 2013; 19: 4837

9a Hong Y, Gao Y, Nie X, Zepp CM. Tetrahedron Lett. 1994; 35: 6631
9b Kobayashi T, Tanaka K, Miwa J, Katsumura S. Tetrahedron: Asymmetry 2004; 15: 185
9c Palmer M, Walsgrove T, Wills M. J. Org. Chem. 1997; 62: 5226
9d Andreana PR, Liu CC, Schreiber SL. Org. Lett. 2004; 6: 4231

10 Boros Z, Falus P, Márkus M, Weiser D, Oláh M, Hornyánszky G, Nagy J, Poppe L. J. Mol. Catal. B: Enzym. 2013; 85: 119
11 Frings K, Koch M, Hartmeier W. Enzyme Microb. Technol. 1999; 25: 303
12 Gotor-Fernández V, Busto E, Gotor V. Adv. Synth. Catal. 2006; 348: 797
13 Chen CS, Fujimoto Y, Girdaukas G, Sih CJ. J. Am. Chem. Soc. 1982; 104: 7294
14 Flask Reaction – General Procedure To a separate small vials containing 0.2 M solutions of (±)-cis-1-amino-2-indanol (298 mg, 2.0 mmol) in THF–EtOAc (0.5 mL, 50 equiv), Novozyme 435^® (20 mg) was added to each vial in one portion, and the turbid solutions were shaken (125 rpm) at 30 °C. After 6 h, 12 h, 24 h, and 48 h, the enzyme was filtered off from the samples. For HPLC analysis, samples were diluted with EtOH (0.5 mL).
15 (1S,2R)-1-Acetamido-2-indanol (2) White solid; [α]_D ²⁰ +11.7 (c 0.25, CHCl₃). IR (neat): 3444, 3299, 1539 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 7.22 (s, 4 H), 6.23 (d, J = 7.2 Hz, NH), 5.32 (dd, J = 8.2, 5.1 Hz, 1 H), 4.57 (td, J = 5.1, 2.3 Hz, 1 H), 3.13 (dd, J =16.5, 5.3 Hz, 1 H), 291 (dd, J = 16.5, 2.1 Hz, 1 H), 2.57 (br s, 1 H), 2.07 (s, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 170.9, 140.6, 139.9, 128.2, 127.2, 125.3, 124.5, 73.5, 57.6, 39.6, 23.3. ESI-HRMS: m/z calcd for C₁₁H₁₄NO₂ ⁺: 192.1019; found: 192.1016 [M + H]⁺.
16 Continuous-Flow Reaction, General Procedure Novozyme 435^® (2.0 g) was packed into a glass column with an aluminum heating jacket for maintaining temperature at 30 °C. The column was fully washed with THF and then fed with a solution of (±)-cis-1-amino-2-indanol (0.1 M) in EtOAc and THF (1:1). At various flow rates (2.0, 1.0, 0.5, 0.25, and 0.1 mL/min), 1 mL of samples were collected. For HPLC analysis, samples were diluted with EtOH (0.5 mL).

Zusatzmaterial

Supporting Information